ING Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $51M | Buy |
885,384
+422,731
| +91% | +$24.3M | 0.25% | 82 |
|
|
2026
Q1 | $28.1M | Buy |
462,653
+137,676
| +42% | +$8.03M | 0.17% | 102 |
|
|
2025
Q4 | $17.5M | Sell |
324,977
-638,156
| -66% | -$30.7M | 0.11% | 140 |
|
|
2025
Q3 | $43.4M | Buy |
963,133
+669,447
| +228% | +$31.3M | 0.24% | 72 |
|
|
2025
Q2 | $13.6M | Buy |
293,686
+290,075
| +8,033% | +$14.2M | 0.08% | 148 |
|
|
2025
Q1 | $220K | Sell |
3,611
-463,419
| -99% | -$27M | ﹤0.01% | 474 |
|
|
2024
Q4 | $26.4M | Sell |
467,030
-567,623
| -55% | -$31.7M | 0.18% | 99 |
|
|
2024
Q3 | $53.5M | Buy |
1,034,653
+873,152
| +541% | +$41M | 0.31% | 57 |
|
|
2024
Q2 | $6.71M | Sell |
161,501
-160,830
| -50% | -$7.2M | 0.04% | 278 |
|
|
2024
Q1 | $17.5M | Sell |
322,331
-165,741
| -34% | -$8.44M | 0.12% | 150 |
|
|
2023
Q4 | $25M | Buy |
488,072
+253,553
| +108% | +$13.3M | 0.2% | 101 |
|
|
2023
Q3 | $13.6M | Sell |
234,519
-1,505,836
| -87% | -$92.3M | 0.12% | 158 |
|
|
2023
Q2 | $111M | Buy |
1,740,355
+1,707,308
| +5,166% | +$114M | 0.84% | 20 |
|
|
2023
Q1 | $2.29M | Sell |
33,047
-166,261
| -83% | -$11.7M | 0.02% | 350 |
|
|
2022
Q4 | $14.3M | Sell |
199,308
-13,860
| -7% | -$1.05M | 0.14% | 124 |
|
|
2022
Q3 | $15.2M | Buy |
213,168
+9,016
| +4% | +$654K | 0.25% | 84 |
|
|
2022
Q2 | $15.7M | Sell |
204,152
-101,071
| -33% | -$7.7M | 0.18% | 99 |
|
|
2022
Q1 | $22.3M | Sell |
305,223
-519,480
| -63% | -$34.9M | 0.22% | 81 |
|
|
2021
Q4 | $51.4M | Buy |
824,703
+471,104
| +133% | +$27.6M | 0.46% | 41 |
|
|
2021
Q3 | $20.9M | Buy |
353,599
+170,082
| +93% | +$11.2M | 0.27% | 64 |
|
|
2021
Q2 | $12.3M | Buy |
183,517
+33,067
| +22% | +$2.16M | 0.2% | 82 |
|
|
2021
Q1 | $9.5M | Sell |
150,450
-15,059
| -9% | -$937K | 0.2% | 84 |
|
|
2020
Q4 | $10.3M | Buy |
165,509
+94,562
| +133% | +$5.81M | 0.23% | 73 |
|
|
2020
Q3 | $4.28M | Buy |
70,947
+15,744
| +29% | +$948K | 0.18% | 80 |
|
|
2020
Q2 | $3.25M | Sell |
55,203
-49,107
| -47% | -$2.94M | 0.14% | 68 |
|
|
2020
Q1 | $5.81M | Sell |
104,310
-117,373
| -53% | -$7.17M | 0.25% | 63 |
|
|
2019
Q4 | $14.2M | Buy |
221,683
+81,870
| +59% | +$4.69M | 0.43% | 45 |
|
|
2019
Q3 | $7.09M | Buy |
139,813
+48,540
| +53% | +$2.28M | 0.18% | 98 |
|
|
2019
Q2 | $4.14M | Buy |
91,273
+5,876
| +7% | +$274K | 0.07% | 177 |
|
|
2019
Q1 | $4.07M | Sell |
85,397
-214,143
| -71% | -$10.7M | 0.09% | 142 |
|
|
2018
Q4 | $15.6M | Sell |
299,540
-29,530
| -9% | -$1.59M | 0.34% | 58 |
|
|
2018
Q3 | $20.4M | Buy |
329,070
+82,928
| +34% | +$4.92M | 0.35% | 55 |
|
|
2018
Q2 | $13.6M | Sell |
246,142
-192,810
| -44% | -$10.4M | 0.26% | 62 |
|
|
2018
Q1 | $27.8M | Buy |
438,952
+204,603
| +87% | +$13.2M | 0.5% | 45 |
|
|
2017
Q4 | $14.4M | Sell |
234,349
-43,432
| -16% | -$2.72M | 0.24% | 57 |
|
|
2017
Q3 | $17.7M | Sell |
277,781
-11,227
| -4% | -$656K | 0.34% | 60 |
|
|
2017
Q2 | $16.1M | Sell |
289,008
-52,584
| -15% | -$2.86M | 0.31% | 51 |
|
|
2017
Q1 | $18.6M | Buy |
341,592
+11,895
| +4% | +$652K | 0.34% | 62 |
|
|
2016
Q4 | $19.4M | Buy |
329,697
+60,569
| +23% | +$3.31M | 0.36% | 56 |
|
|
2016
Q3 | $14.5M | Buy |
269,128
+70,853
| +36% | +$4.55M | 0.17% | 76 |
|
|
2016
Q2 | $14.6M | Buy |
198,275
+45,941
| +30% | +$3.25M | 0.2% | 63 |
|
|
2016
Q1 | $9.73M | Sell |
152,334
-901,538
| -86% | -$56.9M | 0.12% | 109 |
|
|
2015
Q4 | $72.5M | Buy |
1,053,872
+267,504
| +34% | +$17.7M | 0.44% | 58 |
|
|
2015
Q3 | $46.5M | Sell |
786,368
-336,226
| -30% | -$21.3M | 0.32% | 72 |
|
|
2015
Q2 | $74.7M | Sell |
1,122,594
-366,820
| -25% | -$24.2M | 0.4% | 56 |
|
|
2015
Q1 | $96.1M | Buy |
1,489,414
+3,305
| +0.2% | +$207K | 0.48% | 45 |
|
|
2014
Q4 | $87.7M | Sell |
1,486,109
-45,872
| -3% | -$2.59M | 0.41% | 56 |
|
|
2014
Q3 | $78.4M | Sell |
1,531,981
-272,913
| -15% | -$13.6M | 0.46% | 48 |
|
|
2014
Q2 | $87.5M | Sell |
1,804,894
-447,780
| -20% | -$22.1M | 0.44% | 46 |
|
|
2014
Q1 | $117M | Sell |
2,252,674
-60,972
| -3% | -$3.24M | 0.62% | 32 |
|
|
2013
Q4 | $123M | Buy |
2,313,646
+813,514
| +54% | +$41.4M | 0.62% | 33 |
|
|
2013
Q3 | $69.4M | Buy |
1,500,132
+98,610
| +7% | +$4.33M | 0.35% | 69 |
|
|
2013
Q2 | $62.6M | Buy |
+1,401,522
| New | +$60.8M | 0.33% | 83 |
|
Other funds holding BMY
ING Group's BMY Position: Q2 2026 in Review
ING Group increased its Bristol-Myers Squibb (BMY) stake by 91% in Q2 2026, buying an estimated $24.3M and bringing the position to 885,384 shares worth $51M. The position accounts for 0.25% of the portfolio, ranked #82.
ING Group first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $123M in Q4 2013. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- ING Group held 885,384 shares of Bristol-Myers Squibb worth $51M as of Q2 2026.
- ING Group bought 422,731 Bristol-Myers Squibb shares in Q2 2026, an estimated $24.3M.
- Bristol-Myers Squibb made up 0.25% of ING Group's portfolio in Q2 2026, its #82 holding.
- ING Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- ING Group's Bristol-Myers Squibb position peaked at $123M in Q4 2013.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.